scholarly journals US health care utilization and costs in adult patients with atopic dermatitis by disease severity

2022 ◽  
Vol 28 (1) ◽  
pp. 69-77
Author(s):  
Xin Wang ◽  
Natalie N Boytsov ◽  
Magdaliz Gorritz ◽  
William N Malatestinic ◽  
Orin M Goldblum ◽  
...  
Keyword(s):  
Health Care ◽  
Atopic Dermatitis ◽  
Health Care Utilization ◽  
Disease Severity ◽  
Adult Patients ◽  
Care Utilization

Quality Metrics and Health Care Utilization for Adult Patients with Sickle Cell Disease

2019 ◽  
Vol 111 (1) ◽  
pp. 54-61 ◽  
Author(s):  
Monica Ter-Minassian ◽  
Sophie Lanzkron ◽  
Alphonse Derus ◽  
Elizabeth Brown ◽  
Michael A. Horberg
Keyword(s):  
Health Care ◽  
Sickle Cell Disease ◽  
Health Care Utilization ◽  
Sickle Cell ◽  
Quality Metrics ◽  
Adult Patients ◽  
Care Utilization ◽  
Cell Disease

Atopic Dermatitis in US Adults: From Population to Health Care Utilization

2019 ◽  
Vol 7 (5) ◽  
pp. 1524-1532.e2 ◽  
Author(s):  
Jonathan I. Silverberg ◽  
Joel M. Gelfand ◽  
David J. Margolis ◽  
Mark Boguniewicz ◽  
Luz Fonacier ◽  
...  
Keyword(s):  
Health Care ◽  
Atopic Dermatitis ◽  
Health Care Utilization ◽  
Care Utilization

Association of Childhood Atopic Dermatitis With a Higher Risk of Health Care Utilization and Drug Use for Asthma

Dermatitis ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Zarqa Ali ◽  
Charlotte Suppli Ulrik ◽  
Alexander Egeberg ◽  
Jacob Pontoppidan Thyssen ◽  
Simon Francis Thomsen
Keyword(s):  
Health Care ◽  
Atopic Dermatitis ◽  
Drug Use ◽  
Health Care Utilization ◽  
Care Utilization

Evaluation of health-care utilization among adult patients with epilepsy in Germany

2012 ◽  
Vol 23 (4) ◽  
pp. 451-457 ◽  
Author(s):  
Adam Strzelczyk ◽  
Tanja Nickolay ◽  
Sebastian Bauer ◽  
Anja Haag ◽  
Susanne Knake ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Adult Patients ◽  
Care Utilization ◽  
Patients With Epilepsy

scholarly journals A19 HEALTH CARE UTILIZATION DIFFERENCES BETWEEN FIRST NATIONS AND THE GENERAL POPULATION WITH INFLAMMATORY BOWEL DISEASE IN SASKATCHEWAN

2021 ◽  
Vol 4 (Supplement_1) ◽  
pp. 24-25
Author(s):  
J Marques Santos ◽  
S Fowler ◽  
D Jennings ◽  
C Brass ◽  
L Porter ◽  
...  
Keyword(s):  
Health Care ◽  
Inflammatory Bowel Disease ◽  
General Population ◽  
Health Care Utilization ◽  
First Nations ◽  
Disease Severity ◽  
Bowel Disease ◽  
Care Utilization ◽  
Inflammatory Bowel ◽  
Oriented Research

Abstract Background Indigenous patients with inflammatory bowel disease (IBD) have expressed concerns about barriers to access IBD care. The limited evidence of IBD among Indigenous people highlights the need for studies evaluating access to IBD care in this population. Aims We aimed to compare health care utilization between First Nations (FNs) and individuals from the general population (GP) diagnosed with IBD in Saskatchewan (SK). Methods A population-based retrospective cohort study was conducted using administrative health databases of SK from 1998 to 2017 fiscal years. As a patient-oriented research initiative, outcomes of interest were chosen in collaboration with Indigenous patients and family advocates. A validated algorithm requiring multiple health care contacts was applied to identify incident IBD cases. The self-declared FN status variable was used to divide IBD cases between FNs and the general population (GP). To balance the groups, 1:5 age and sex matching was applied. Cox-proportional models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95%CI). Stratified analysis was completed for those diagnosed before and after 2008 (pre- and post-biologic eras). Results A matched cohort with 696 IBD incident cases was created (FN=116, GP=580). Comparing health care utilization of FNs and individuals from the GP with IBD, there were no statistically significant differences in outpatient gastroenterology visits (FNs=81.0%, GP=83.6%), colonoscopies (FNs=91.4%, GP=86.9%), and surgeries for IBD (FNs=31.0%, GP=33.5%). We observed differences in prescription claims for any medication for IBD (FNs=79.3%, GP=89.3%) and 5-aminosalicylic acid (5-ASA) claims (FNs=75.9%, GP=81.4%). The HRs adjusted by rural/urban residence and diagnostic type showed differences in prescription claims for any IBD medication (HR=0.52, 95%CI 0.41–0.65) and 5-ASA (HR=0.57, 95%CI 0.45–0.72). In the pre-biologic era, FNs had a lower risk of having a prescription claim for any IBD medication (HR=0.32, 95%CI 0.23–0.45) and 5-ASA (HR=0.33, 95%CI 0.24–0.47), respectively. These differences were not significant in the post-biologic era. Conclusions Our study identified an inverse association between FN status and having prescription medication claims for IBD in SK. We considered multiple confounding variables when evaluating this association but could not control by disease severity. Thus, this association might reflect a barrier to access IBD medications or that FNs with IBD might present a milder disease. Further studies should continue evaluating access to IBD care, medication use, and disease severity among FNs living with IBD. Funding Agencies Saskatchewan Centre for Patient-Oriented Research (SCPOR), Saskatchewan Health Research Foundation (SHRF), and College of Medicine, University of Saskatchewan.

scholarly journals Radiographic disease severity in chronic rhinosinusitis patients and health care utilization

2021 ◽  
Author(s):  
Mitesh P. Mehta ◽  
Kevin Hur ◽  
Caroline P. E. Price ◽  
Stephanie Shintani‐Smith ◽  
Kevin C. Welch ◽  
...  
Keyword(s):  
Health Care ◽  
Health Care Utilization ◽  
Chronic Rhinosinusitis ◽  
Disease Severity ◽  
Care Utilization ◽  
Radiographic Disease
Sign in / Sign up

Export Citation Format

Share Document